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In the past few years several automatic and semi-automatic PET segmentation methods for 
target volume definition in radiotherapy have been proposed. The objective of this study is to 
compare different methods in terms of dosimetry. For such comparison, a gold-standard is 
needed. For this purpose realistic GATE simulated PET images were used. Three lung cases 
and three H&N cases were designed with various shapes, contrasts and heterogeneities. Four 5 
different segmentation approaches were compared: fixed and adaptive threshold, a fuzzy C-
Mean and the fuzzy locally adaptive Bayesian method. For each of these target volumes an 
IMRT treatment plan was defined. The different algorithms and resulting plans were 
compared in terms of segmentation errors and ground-truth volume coverage using different 
metrics (V95, D95, homogeneity index and conformity index). The major differences between 10 
threshold based methods and automatic methods occurred in the most heterogeneous cases. 
Within the two groups, the major differences occurred for low contrast cases. For 
homogeneous cases, equivalent ground-truth volume coverage were observed for all methods 
but for more heterogeneous cases significantly lower coverage was observed for threshold-
based methods. Our study demonstrates that significant dosimetry errors can be avoided by 15 





The use of multimodality Positron Emission Tomography / Computed Tomography (PET/CT) 
images, have been shown to improve target volume definition for radiotherapy treatment 20 
planning (RTP) by reducing in particular inter and intra observer variability of the target 
volume delineation (Steenbakkers et al 2006, Buijsen et al 2012, Daisne et al 2005). PET 
images are also considered for applications such as dose redistribution (South et al 2008), 
dose boosting (Lee et al 2008, Chao et al 2001) or dose painting
 
(Bentzen 2005, Sovic et al 
2009). However the limited spatial resolution of PET systems (4 to 5 mm in the center of the 25 
field of view) results in significant partial volume effects (PVE) (Soret et al 2007). In 
addition, due to the statistical nature of the PET acquisition, images are affected by a 
significant level of noise. Consequently manual delineation of PET volumes is tedious, time 
consuming, and prone to high inter- and intra-observer variability (Hatt et al 2010b, Hatt et al 
2011a). In order to facilitate and improve functional volume delineation, several fast and 30 
semi-automatic algorithms have been proposed in the past few years (Belhassen et al 2010, 
Aristophanous et al 2007, Hatt et al 2009). However, most of the methods currently used in 
clinical practice, are still based on the use of some form of binary threshold, either fixed (Erdi 
et al 1997, Paulino et al 2004), or adaptive using tumour-to-background (T/B) ratios (Daisne 
et al 2003, Nestle et al 2005). The major limitations of these algorithms are their dependency 35 
on optimization using phantom acquisitions of homogeneous spheres and the user-dependent 
manual determination of the background value. As a result they often fail to provide 
satisfactory delineation of tumours characterised by heterogeneous activity distributions and 
do not provide reproducible results for small tumors with low contrast (Hatt et al 2011b, 
Nestle et al 2005). Considering the plethora of segmentation approaches based on various 40 
advanced image processing paradigms currently available (Hatt et al 2012, Zaidi et al 2011) 
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there is a lack of consensus regarding the automatic delineation of PET uptakes, with no clear 
guidelines on how to incorporate PET information into target definition.  
Several studies have already compared the target volumes obtained using different 
automatic methods with the CT target volume in various tumour localizations (Schinagl et al 45 
2007). However, to our knowledge the impact of the PET delineation methodology on the 
radiotherapy planning dosimetry has been assessed only by a few investigators (Geets et al 
2006). Therefore the objective of this work was to investigate the actual impact of accurate 
PET uptake delineation in RTP in terms of dosimetry. In order to evaluate the potential 
impact the different treatment plans have to be compared to one gold standard volume 50 
coverage. For this purpose dosimetry was computed on simulated datasets in order to ensure 
knowledge and control of the necessary ground-truth. 
1 Materials and Methods 
1.1 Datasets 
The data used in this work are simulated 
18
F-FDG PET images based on corresponding 55 
clinical PET/CT datasets
 
(Le Maitre et al 2009), the objective being to have clinically realistic 
images (in terms of anatomy, radiotracer distribution, voxel sampling, texture and noise 
levels) with a known voxel-based ground truth. One clinical PET/CT dataset was also 
included in our study in order to compare the range of results with those obtained using the 
simulated datasets. 60 
The simulation process consists of two major steps: the creation of the patient’s model and 
the simulation of the PET acquisition. We chose to focus on two different tumour 
localizations where radiotherapy is a major treatment regime; namely non-small cell lung 
cancer (NSCLC) and head and neck (H&N) cancer, using the NCAT (Non-Uniform Rational 
B-Splines based Cardiac Torso)
 
(Segars 2001) and the Zubal
 
(Zubal et al 1994) phantoms 65 
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respectively. In this work the lung cases were simulated without respiratory motion in order to 
improve the robustness of the analysis considering the objectives targeted in this work.  
Although the NCAT phantom is based on the use of Non-Uniform Rational B-Splines 
(NURBS) allowing model flexibility, the details for H&N anatomical structures are not 
complete (for example the parotid glands are not modelled). This motivated the use of the 70 
more detailed Zubal phantom for the H&N cases. In order to provide more interesting and 
challenging comparison cases, complex tumour shapes and activity distributions were 
simulated based on our previously proposed methodology
 
(Le Maitre et al 2009). In each of 
these phantoms, organs are associated with a label defining an activity level and an 
attenuation coefficient. The activity levels were derived from region of interest (ROI) analysis 75 
on corresponding clinical images used as model for designing the simulated cases. 
Acquisitions of PET images with a Philips GEMINI PET scanner (2 minutes per bed position) 
were simulated using the Monte Carlo simulation tool Geant4 Application for Tomography 
Emission (GATE)
 
(Jan et al 2004) combined with a model of the PET scanner previously 
developed and validated (Lamare et al 2006). The resulting simulated list-mode data were 80 
subsequently reconstructed using the OPL-EM (One-Pass List Mode Expectation 
Maximization) reconstruction algorithm with previously optimized parameters (Lamare et al 
2006). Apart from these simulated functional images corresponding synthetic CT datasets, 
necessary for the dosimetry calculations, were derived by replacing each label in the 
simulated phantoms voxelized maps by the corresponding Hounsfield Unit (HU). 85 
Three localizations were considered for both the NSCLC and the H&N cases. Within some 
of these localizations, different tumour sizes, contrasts and heterogeneities were designed in 
order to compare for each of these localizations the impact of the delineation accuracy on the 
final dosimetry. Figure 1 shows the six simulated lung and H&N tumours with the 
corresponding variations in heterogeneity and contrast considered. The first NSCLC case was 90 
6 
 
placed in the middle lobe of the right lung. Three sizes of intra-tumour high uptake regions 
were designed (representing 12%, 41% and 53% of the overall tumour volume for cases 1a, 
1b and 1c respectively). The contrast between high and low uptake areas was simulated as 
2:1, 2:1 and 1.8:1 for case 1a, 1b and 1c respectively. The second case was placed in the 





). The contrast between the high and low uptake areas was set at 2:1 and 
1.8:1 for cases 2a and 2b respectively. The third tumour was placed in the lower lobe of the 




 for case 3a and 3b 
respectively). For the three H&N cancer cases, both homogeneous and heterogeneous tumor 
activity distributions were considered. The first tumour was simulated with a homogeneous 100 
uptake and placed in the mandible with two T/B contrasts (9.5:1 and 1.8:1). For the second 
case the same tumour shape was simulated with heterogeneous (contrast between the two 
uptake areas of 1.7:1) and homogeneous activity distribution (T/B ratio of 3:1). The third 
tumour was simulated as heterogeneous considering two different locations of the 
heterogeneous sub-volumes within the tumour. In case 3a the high uptake area was placed at 105 
the outer rim of the tumour with a contrast of 2.3:1, while in case 3b the high uptake and low 
uptake positions were reversed and the contrast was set at 2.6:1. 
One clinical H&N case was finally included in our study (see Figure 7) in order to allow a 
comparison with the results obtained using the simulated data.  The data was acquired on a 
GE Discovery PET/CT system. The images were reconstructed using Fourier Rebinning 110 
(FORE) and voxel size of 4.7x4.7x3.3mm
3
. The approximate measured T/B was 12:1.  
 
1.2 Tumour Volume definition 
As already mentioned the use of simulated datasets allows knowing exactly the ground-
truth volume, which was considered here to be the Gross Tumour Volume (GTV). Within the 115 
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context of this study, GTVs were defined on the PET images only, the assumption being that 
there was no part of the anatomical volume without elevated PET uptake. Four automatic 
segmentation algorithms were compared. Two are based on the use of thresholding 
considering both fixed and adaptive threshold, while the other two are based on more 
“advanced” image segmentation paradigms; namely the Fuzzy C-mean (FCM) clustering 120 
(Boudraa et al 1996) and the Fuzzy Locally Adaptive Bayesian (FLAB) algorithm (Hatt et al 
2009, Hatt et al 2010a, Hatt et al 2011a).  
For the fixed threshold a value of 42% of the maximum was used based on the original 
work by Erdi et al 1997, denoted from here onwards as T42. The adaptive thresholding 
method (Daisne et al 2003) is based on the signal to background ratio (SBR): 125 
, where a and b are scanner-specific parameters obtained by linear 
regression. We calculated a and b with several simulations of the IEC phantom (NEMA 2-
2001 IQ Phantom, T/B ratios of 4:1, 6:1, 8:1, 12:1 and 16:1) using the Philips GEMINI PET 
scanner model (2 minutes acquisition time), and reconstructed with 4x4x4mm
3
 voxels using 
the OPL-EM algorithm. For each sphere in the IEC phantom (excluding the 10mm sphere due 130 
to the large voxel sizes and partial volume effects) the SBR was measured and the threshold 
which led to the lowest error was found by exhaustive search (all the possible cases were 
tested and the best one was chosen). Linear regression was conducted for all these points 
(threshold as a function of SBR only, as the approach does not assume any a priori 
information regarding object size) in order to determine parameters a and b for this particular 135 
data simulation and reconstruction configuration (a=34.8 and b=59.2). In order to evaluate the 
influence of the background region placement during adaptive thresholding segmentation, two 
different users were instructed to manually define a background ROI (a few cm away from the 
tumors for lung cases, and in low uptake regions for H&N), which led to two different 
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thresholds and therefore two different segmentation results (denoted from here onwards as A1 140 
and A2). 
FCM and FLAB are both able to handle homogeneous and heterogeneous uptakes, 
allowing in principle to differentiate several classes within the tumour whereas threshold 
based methods only differentiate tumour and background. FCM is a clustering based method 
that only considers the intensities of voxels and which has been previously used for PET 145 
segmentation (Boudraa et al 1996, Kim et al 2007). It consists in defining for each voxel a 
degree of membership to a cluster by minimizing the distance between the voxel value and 
cluster center. Although it is based on a fuzzy model, this process does not explicitly model 
PVE in PET imaging. FLAB is a method based on statistical and fuzzy modelling specifically 
accounting for PET image characteristics such as noise and low spatial resolution (Hatt et al 150 
2009). In contrast to FCM, it also takes into account spatial correlation between neighbouring 
voxels in a local fashion which makes it more robust to noise. 
Although any identified tumour sub-volumes can be of interest for dose painting or dose 
boosting purposes, only a uniform dose prescription to the tumour volume was considered in 
this study in order to allow a fair comparison of the segmentation approaches considered. 155 
Therefore, for the cases where FLAB and FCM delineated two different sub-volumes within 
the tumour, the union of the two sub-volumes was considered as the target volume. For the 
clinical case, GTV was only delineated with FLAB and one adaptive threshold (denoted from 
here on as FLAB and A) applied separately to two ROIs, the first for the large high contrast 
and heterogeneous uptake, the second for the several lower uptakes close to each other (see 160 
figure 7).  
The segmentation processes resulted in binary images, containing tumour and background 
voxels, which were transformed into DICOM datasets using the ITK DICOM library in order 
to import them within the treatment planning system. GTVs were then defined by 
9 
 
thresholding these masks within the Pinnacle
TM
 treatment planning system (Philips 165 
Healthcare, research version 8.7y). The Clinical Target Volumes (CTVs) were derived from 
the GTVs by adding a 3mm margin for microscopic extensions. Since no respiratory motion 
or setup errors were considered in our simulated datasets, the CTV considered is equivalent to 
the PTV. 
1.3 IMRT Treatment planning 170 
The Pinnacle
TM
 treatment planning system was used for IMRT planning and dose 
calculation. For the lung cancer cases 5 photon beams of 6MV nominal energy with angles of 
0°, 72°, 144°, 216° and 288° were used. For the H&N cases, 7 photon beams of 6MV nominal 
energy with angles of 0°, 50°, 100°, 150°, 210°, 260° and 310° were used. These choices were 
made according to usual clinical plans as routinely defined in our radiotherapy department. 175 
A uniform dose was prescribed within the PTV. According to doses clinically used, 66Gy 
was prescribed to the PTV in 2Gy fractions for the lung cases. For the H&N we prescribed 
50Gy to the volume enclosing the tumour and the node extensions (PTV1). Then an 
additional dose of 20Gy was prescribed specifically to the tumour volume (PTV2) in 2Gy 
fractions, for a total of 70Gy delivered to the tumour (PTV2). The constraints to the organs at 180 
risk (OARs) considered for the IMRT plans are summarized in Tables 1 and 2. The Direct 
Machine Parameters Optimisation (DMPO) algorithm was used for the dose calculation. 
1.4 Plan comparison 
GTVs delineated on PET images by the four approaches were compared to the ground-
truth. The comparison metrics used were volume error (VE), sensitivity and positive 185 
predictive value (PPV). As the CTV (=PTV) was derived from the GTV with an added 3 mm 
margin, the different plans were compared to the volume derived from the ground-truth 
volume with the addition of the same 3 mm margin (PTVGT), in order to avoid a systematic 
bias of volume overestimation. 
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Several measures can be used to assess the quality of volume coverage of a treatment plan. 190 
We chose to calculate the percentage of target volume (PTVGT) receiving 95% of the 
prescribed dose (V95) and the percentage of dose received by 95% of the target volume (D95). 
The homogeneity of the dose within the target volume was also assessed by the homogeneity 
index (HI) expressed by: 
  (1) 
where, Dp is the prescribed dose, Dmin and Dmax is the dose for 98% and 2% respectively of 195 
the target volume. The conformity of the treatment plans to the PTVGT was finally assessed 
using the conformity index (see Figure 2):  
 
 (2) 
where, TVir represents the PTVGT which is within the reference isodose, TV is the target 
volume (PTVGT) and Vir the volume of the reference isodose (here the 95% isodose). The first 
factor represents the target volume coverage (V95), whereas the second factor represents the 200 
volume of normal tissue irradiated by the reference isodose. 
The differences between the segmentation algorithms and the different measures of 
ground-truth volume coverage (V95, D95, HI and CI) were assessed with the Kruskal-Wallis 
(K-W) test which is an extension of the Wilcoxon rank-sum test for three or more groups and 
non-paired data (we considered here five groups, FLAB, FCM, T42, A1 and A2). It allows 205 
comparison of parameters with small samples and without a Gaussian assumption which is 
the case here. Two statistical tests were conducted, the first on all data together and the 




2.1 Delineation performance 210 
All segmentation results were compared to the ground-truth to evaluate the delineation 
accuracy of the different algorithms considered. Figure 3 provided VE, sensitivity and PPV 
with respect to the ground-truth for the different segmentation algorithms considered. Figure 
3(a) shows the mean VE (which can be negative or positive) and associated standard 
deviation (SD). Figure 3(b) provides the mean sensitivity and PPV and their associated SD 215 
over all cases. Overall, the advanced image segmentation approaches demonstrated higher 
accuracy, with a mean VE of -2±11% and 12±37%, a mean sensitivity of 0.86±0.06 and 
0.88±0.05, and a mean PPV of 0.87±0.06 and 0.83±0.15 for FLAB and FCM respectively. In 
comparison, the threshold-based methods resulted in a mean VE of -2±107.0%, -35±27.0% 
and -31±26.0%, a mean sensitivity of 0.66±0.26, 0.61±0.24 and 0.64±0.22 and a mean PPV of 220 
0.89±0.23, 0.96±0.06 and 0.96±0.06 for T42, A1 and A2 respectively. The mean volume error 
of T42 was quite low (-2%), however the associated SD was the highest (107%). The two 
adaptive thresholds led to quite similar results with under-estimated volumes due to uptake 
heterogeneities, therefore leading to higher PPV but much smaller sensitivity. 
Figure 3(c) to (f) illustrates the same segmentation results with data separated into 225 
homogeneous (H&N case 1 and 2b, lung case 3) and heterogeneous (H&N cases 2a and 3, 
lung cases 1 and 2) cases. For homogeneous tumours FLAB, A1 and A2 led to similar results 
(mean VE ~-13%, mean sensitivity and PPV of ~0.85). On the other hand, FCM and T42 
overestimated tumour volume with a positive VE (18±56% and 70±151% respectively), and 
sensitivity (0.88±0.04 and 0.86±0.12 respectively) higher than the PPV (0.83±0.23 and 230 
0.73±0.32 respectively). For heterogeneous cases, threshold based methods underestimated 
the volume (mean VE, sensitivity, and PPV of -45%, 0.5 and 0.98 respectively), whereas 
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advanced methods were able to handle these heterogeneities (mean VE of 2.3±10.7% and 
9.7±21.2% for FLAB and FCM respectively, and mean PPV and sensitivity of ~0.85). 
2.2 Tumour volume coverage 235 
For the lung case 1a and 1b, PTVFLAB and PTVFCM could not receive 95% of the prescribed 
dose but GTVs did (V95 of 89% (89%) and 83% (85%) for case 1a (1b) for PTVFLAB and 
PTVFCM respectively). For lung case 1c none of the PTVs defined by any delineation method 
considered could receive 95% of the prescribed dose (V95 of 89%, 80%, 94%, 92% and 92% 
for PTVFLAB, PTVFCM, PTVT42, PTVA1 and PTVA2 respectively) but the GTVs did. For all 240 
other cases (lung cases 2 and 3, H&N cases) PTVs received 95% of the prescribed dose. No 
planning were produced for the fixed threshold volumes for H&N cases 1b and 3b since they 
grossly overestimated the ground-truth volume by +333% and +58% respectively. Similarly 
no planning was produced for FCM in H&N case 1b (+118% overestimation relative to the 
ground-truth volume). 245 
Figure 4 shows the whole procedure for one heterogeneous lung case (case 1a). The 
different GTVs, resulting isodoses and Dose Volume Histograms (DVH) obtained by the four 
segmentation methods are illustrated. Advanced methods resulted in the largest PTV in this 




 for FLAB 







for T42, A1 and A2 respectively) and better PTVGT volume coverage (V95 of 
84.7%, 83.9%, 60.7%, 53.7% and 63.6% for FLAB, FCM, T42, A1 and A2 respectively). In 
addition, they also resulted in higher doses delivered to OARs (D20 and D35 for the lungs of 
26.5Gy, 26.5Gy, 15.6Gy and 16.6Gy respectively) compared to the threshold based methods 
(D20 (D35) to the lungs of 21.1Gy (10.5Gy), 19.1Gy (7.6Gy), and 20.1Gy (8.3Gy) for T42, A1 255 
and A2 respectively). All these doses were however within the OARs constraints (30Gy and 
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20Gy for D20 and D35 respectively). Values (Vir, V95, D20 and D35) for this case are reported in 
table 3. 
Figure 5(a) shows the mean and SD over all cases for V95 and D95 (in %) computed for all 
delineation approaches. FLAB and FCM resulted in higher ground-truth coverage (mean V95 260 
of 91.6%±6.3% and 90.8%±7.0% respectively, mean D95 of 91.6%±5.9% and 89.0%±9.0% 
respectively) than the threshold based methods (mean V95 and D95 below 82.3±15.0% and 
79.3±21.1% respectively). Figure 5(b) shows the mean HI. This index was lower for FLAB 
and FCM (17.9±8.3 and 23.0±14.1) than for the threshold based methods (mean >29.8±24.7). 
Figure 5(c) shows the CI mean and associated SD. No significant differences were observed 265 
between the various delineations strategies with 0.68±0.11, 0.66±0.08, 0.63±0.08, 0.63±0.09 
and 0.64±0.08 for FLAB, FCM, T42, A1 and A2 respectively. Differences between 
delineation strategies were not significant (p>0.05) for homogeneous activity distributions 
within tumours (H&N cases 1 and 2b) and the necrotic case (lung case 3), but were significant 
(p<0.02) in terms of V95 and D95 for the heterogeneous cases (see figure 6a and 6b). For all 270 
heterogeneous cases, mean V95 was 89.1±6.4% and 88.5±6.9% for FLAB and FCM 
respectively, whereas for threshold-based methods significantly (p<0.05) lower values and 
higher standard deviations were observed (73.0±15.4%, 72.7±16.4% and 75.4±13.8% for 
T42, A1 and A2 respectively). By comparison, mean V95 for homogeneous cases were 
globally higher (>95%) with lower SD (<2%) independently of the delineation strategy. 275 
Similar conclusions can be drawn regarding D95 and HI. When considering heterogeneous 
cases, mean D95 was 89.4±6.1% and 86.3±9.3% for FLAB and FCM respectively, whereas it 
significantly (p<0.05) dropped to 71.0±19.8% for T42, and 69.1±24.2% and 71.0±21.5% for 
A1 and A2 respectively. HI associated with the FLAB and FCM delineations were 21.3±8.2% 
and 27.9±13.4% respectively, rising to 38.8±21.8, 41.0±26.0% and 39.6±25.0% for T42, A1 280 
and A2 respectively (p>0.05). On the other hand, for the homogeneous cases the mean D95 
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and HI were not significantly different (p>0.05) across the various delineation strategies, with 
D95 >95% and HI <13%. 
2.3 Organ at risk sparing 
The highest delivered dose to the spinal cord over all the lung cases and segmentation 285 
algorithms was 41.9Gy. The maximum dose to 100% of the heart over all cases was 0.58Gy. 
Table 4 provides the mean and ranges (min and max) over all cases of the delivered doses to 
the spinal cord and the lungs. 
For the H&N cases the maximum dose to the spinal cord and the brain stem was 49.7Gy 
and 42.8Gy respectively. The highest dose to the spinal cord over all the H&N cases was 290 
inferior to 50Gy (value reached for case 2). Table 5 contains the mean and ranges (min and 
max) over all cases of the delivered doses to the spinal cord and the parotids. 
2.4 Clinical case 
For the clinical case no ground-truth was available. Two different CTVs were obtained 
using the two most accurate, established on the simulated datasets, amongst each group of 295 
methods (CTVFLAB and CTVA for adaptive thresholding) and for each CTV, by combining the 
delineations performed separately on the large high contrast and heterogeneous uptake on the 
one hand, and the small, lower contrast several uptakes on the other hand (see ROIs in figure 




. V95 was 99.5% and 99.9% 
PTVFLAB and PTVA respectively. The doses to parotids were equivalent for both delineations 300 
(D20, D40 and D60 for the left parotid were 26Gy, 16Gy and 11Gy for FLAB and 26Gy, 15Gy 
and 10Gy for adaptive thresholding). The maximum dose to spinal cord was 44Gy and 




Several delineation approaches have been proposed in the past few years for PET uptake 305 
volume delineation on PET images. One of the objectives is to offer improved target volume 
delineation for radiotherapy planning in order to facilitate the incorporation of the PET 
information into radiotherapy treatment. Within this context, the objective of this study was to 
investigate the impact of the actual accuracy of such approaches on RTP in terms of 
dosimetry. The data used in this work were simulated PET images which allowed knowledge 310 
and control of the tumours position, size, shape and activity distribution. Four PET image 
segmentation algorithms were considered and grouped into threshold based (fixed and 
adaptive) and automatic methods (FLAB and FCM). The segmentation accuracy was assessed 
with respect to the known ground-truth. For each of the obtained delineations, an IMRT plan 
was subsequently designed and all the plans were compared in terms of ground-truth volume 315 
coverage and OARs sparing using standard metrics. 
The most significant differences in segmentation accuracy were observed for tumours 
exhibiting heterogeneous uptake for which the automatic approaches were able to delineate 
the entire volume, whereas the threshold-based algorithms usually significantly 
underestimated such volumes (high PPV and low sensitivity). The main differences between 320 
fixed and adaptive threshold methods were obtained for the lowest contrast cases in which 
adaptive thresholding was more accurate than the fixed threshold which highly overestimated 
the volume in these cases (+333% and +58% for H&N case 1b and 2b respectively). 
Similarly, FLAB provided more accurate results than FCM on these cases. The low mean VE 
and its high associated SD for fixed threshold can be explained by the fact that heterogeneous 325 
cases resulted in underestimation of the volume whereas low contrast cases resulted in 
overestimation of the volume. 
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For the measures assessing the quality of the ground-truth volume coverage, significant 
differences in V95, D95 were observed between the automatic approaches (FLAB, FCM) and 
threshold-based (T42, A1, A2) but not within each of the two groups. Larger standard 330 
deviations were observed for the threshold based methods compared to the automatic 
approaches. This can be explained by the fact that these approaches had equivalent 
performance for both heterogeneous and homogeneous cases, whereas threshold-based 
methods consistently failed in delineating heterogeneous uptakes, which resulted in 
insufficient volume coverage. No significant differences were observed for the CI between all 335 
the algorithms in the heterogeneous group (p=0.24). This can be explained by the fact that 
two factors affect this index: V95 ( ) and ( ) which is a measure of how much 
normal tissue is irradiated by the reference dose (here 95% of the prescribed dose). For highly 
underestimated tumour volumes the V95 is consequently low but only a few parts of normal 
tissue are irradiated, a factor that improves the CI.  340 
For lung cases 1 and 2, as the threshold based method only delineated the sub-volumes 
with higher uptake (see Figure 4 for case 1a), the larger this sub-volume (expressed as a 
percentage of the overall tumour volume), the better the volume coverage was when 
considering threshold-based methods. Lung case 1 for example was simulated with three 
heterogeneous sub-volumes sizes (12%, 41% and 53% of the overall tumour volume). The 345 
corresponding D95 was 29.6%, 64.2% and 66.8% for A2. Similar results were observed for the 
second lung case with sub-volumes of 12% and 38% of the overall tumour volume, and 
corresponding D95 values of 61.6% and 69.5% respectively. 
For the clinical case, PTVFLAB was larger than PTVA. The PET uptake was indeed slightly 
heterogeneous and exhibited different levels of uptake (see illustration in Figure 7). Similar 350 
differences between the two approaches were therefore observed as in the simulated datasets. 
Similarly, due to higher tumour coverage, the resulting dose to spinal cord was higher for 
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FLAB than for adaptive thresholding (Dmax of 44Gy and 42.8Gy respectively). However, both 
were inferior to the constraint of 45Gy. 
Our results demonstrate that there might be a significant impact on the dosimetry of IMRT 355 
plans including the PET uptake within the tumour volume and the method used to delineate 
this uptake. There is therefore a need for accurate and robust automatic PET heterogeneous 
uptake delineation in order to incorporate functional information into radiotherapy planning, 
especially for heterogeneous uptake tracer distributions within the tumour target volumes as 
well as for low contrast cases. In this work, we used FCM and FLAB, however several other 360 
recent methods have been developed and validated against such heterogeneous or low contrast 
PET uptakes (Zaidi et al 2011, Hatt et al 2012) and should therefore lead to similar dosimetry 
results.  
A limitation of the current study is the lack of respiratory motion concerning the lung cases 
and the lack of set-up errors in all of the cases considered. However, one well recognised 365 
result of respiratory motion in PET imaging is an overall tumour contrast reduction and as 
demonstrated in this study the use of segmentation algorithms able to accurately handle low 
contrast lesions can only be advantageous for dosimetry purposes. Another limitation is that 
our study was restricted to PET-based GTV. A future extension of the proposed framework 
introduced here could be the addition of anatomical/morphological imaging such as CT or 370 
MRI in the GTV delineation, by comparing results of multimodality image segmentation 
approaches dedicated to multi modal treatment planning in radiotherapy (Hand et al 2011)  
with respect to a more complete ground-truth including anatomical and functional tumor 
volumes.    
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4 Conclusions 375 
A framework was proposed to evaluate the impact of the accuracy of PET uptake volume 
delineation on the dosimetry of radiotherapy treatment plans. Simulated PET images and their 
corresponding ground-truth were imported into the TPS in order to evaluate the impact of the 
accuracy of the different delineations on the dosimetry. The accuracy of segmentation was 
assessed by volume errors, sensitivity and positive predictive value with respect to the 380 
ground-truth of the simulation. The corresponding quality of the treatment plans was 
evaluated using the same ground-truth volume and several measures (V95, D95, homogeneity 
index and conformity index). Automatic advanced methods demonstrated better accuracy than 
threshold-based methods especially for heterogeneous tracer uptake resulting in significantly 
better target volume coverage (mean V95 of 91.6%) than threshold based methods (mean V95 385 
below 82.3%). On the other hand, for more homogeneous tracer uptake distribution, no 
significant differences were observed in terms of dosimetry between the delineation 
strategies. As expected, an under-estimation of the true tumour uptake volume resulted in 
insufficient target volume coverage but in better OARs sparing as assessed by dose 
constraints, whereas an over-estimation of the ground-truth volume resulted in better coverage 390 
but lower OARs sparing, although still within the dose limits.  
In conclusion, although for homogeneous PET uptakes, simple threshold based methods 
may be sufficient to provide accurate PET GTV delineation for treatment planning, our study 
demonstrate that significant dosimetry errors can be avoided by using more advanced image 





Table 1: Constraints to the OARs for the lung cases 
Table 2: constraints to the OARs for the head and neck cases 
Table 3: Volume of reference isodose (Vir), V95 and D20 and D35 for lungs for lung case 1a 
(the case illustrated in Figure 4).  
Table 4: Doses to the OARs for the lung cases 
Table 5: Doses to the OARs for the head and neck cases 
 
Figure captions 
Figure 1: Illustration of the 6 tumour cases (3 lung tumours and 3 head and neck tumours). 
For each case (same patient) varying configurations of contrast and heterogeneity (a-c) were 
considered. 
Figure 2: Illustration of the conformity index. 
Figure 3: Mean and associated standard deviation for the different algorithms considered and 
over all the cases, for (a) volume error (%), (b) positive predictive value and sensitivity. 
Figure 4: Illustration of the complete procedure and results for lung case 1a : (1) target 
volume definition, (2) isodoses for the four different plans and (3) DVH for the four plans 
with dose on PTVGT. 
Figure 5: Mean and associated SD calculated on PTVGT for the different algorithms for (a) 
V95 and D95, (b) homogeneity index and (c) conformity index. 
Figure 6: Kruskall-Wallis results on the heterogeneous group for (a) V95 and (b) D95 
Figure 7: Illustration of the clinical case with the two delineations: in red FLAB and in green 
adaptive threshold: (a) Coronal slice, (b) Sagital slice and (c) Transverse slice. The Two 
yellow contours denote the two separate ROIs in which both algorithms were applied in order 
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) V95 (%) D20 D35 
FLAB 141.6 84.7 26.5 15.6 
Fixed Threshold 89.7 60.7 21.1 10.5 
Adaptive Threshold 1 80.3 53.7 19.1 7.6 
Adaptive Threshold 2 95.8 63.6 20.1 8.3 








 Mean Dmax to spinal 
cord 
Mean D20 to both 
lungs  
Mean D35 to both 
lungs 
FLAB 35.4 (25.5-41.9) 23.3 (17.8-28.0) 12.6 (6.8-17.1) 
FCM 34.9 (23.4-40.9) 24.1 (18.5-29.1) 14.1 (10.0-18.1) 
Fixed Threshold 33.2 (24.6-38.8) 19.7 (12.6-25.1) 10.0 (6.5-15.1) 
Adaptive Threshold 1 32.9 (24.6-38.6) 19.5 (12.9-25.5) 9.7 (6.5-15.8) 
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spinal cord 
Mean D20 to parotids 
Left / Right 
Mean D40 to parotids 
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Figure 4 
 
(1) Tumour volume definition 
(2) Isodose lines 
FLAB 
Adaptive threshold 2 
Fixed threshold 
Adaptive threshold 1 
FLAB 
Fixed threshold Adaptive threshold 2 
FCM 
(3) Dose Volume Histogram 
PTVGT FLAB 
PTVGT Adaptive threshold 2 
PTVGT Adaptive threshold 1 
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